This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Chemo-Sero-Therapeutic Research Institute, National Institute of Infectious Diseases, Tokushima University. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kumamoto-ken, JP (2015)
- Kumamoto, JP (2016)
Company Filing History:
2 out of 151 
1 out of 37 
1 out of 42 
Years Active: 2015-2016
Title: Innovations by Hirotoshi Nakano: Advancements in Neurotoxin Research
Introduction
Hirotoshi Nakano, an innovative inventor hailing from Kumamoto-ken, Japan, has made notable contributions to the field of neurotoxin research. With two patents to his name, Nakano has paved the way for novel therapies aimed at treating muscle overactivity.
Latest Patents
Nakano's latest patents demonstrate his groundbreaking work in the development of a novel type of Atoxin preparation. This preparation acts as a neuromuscular transmission blocking agent that utilizes a highly purified type Atoxin derived from the infant botulism pathogen. The medicament has shown rapid efficacy and is characterized by reduced diffusiveness, providing a broader safety margin for therapeutic use in conditions involving muscle overactivity.
In addition, Nakano has developed a method for the quantification of neurotoxin. This innovative approach allows for the precise measurement of the muscular relaxing activity of neurotoxins. By administering a neurotoxin to the hind leg muscle of a non-human mammal and analyzing the compound muscle action potential (CMAP), the method enhances sensitivity and accuracy in quantifying neurotoxin efficacy, making it a significant advancement in the field.
Career Highlights
Throughout his career, Nakano has collaborated with prestigious organizations, including the Chemo-sero-therapeutic Research Institute and the National Institute of Infectious Diseases. His work at these institutions has contributed significantly to the understanding and application of neurotoxins in medical treatments.
Collaborations
Hirotoshi Nakano has worked alongside esteemed colleagues such as Tetsuhiro Harakawa and Yasushi Torii. These collaborations have facilitated a rich exchange of ideas and expertise, leading to innovative solutions in neurotoxin research.
Conclusion
Hirotoshi Nakano's pioneering work in the field of neurotoxins reflects his dedication to advancing medical treatments for conditions involving muscle overactivity. His patents not only highlight his inventiveness but also contribute valuable knowledge and innovation to the medical community. Through his continued efforts, Nakano remains a significant figure in neurotoxin research, shaping the future of therapeutic interventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile